An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxicAriel Fernández, Gabriel Lopez‐Berestein|Journal of Clinical Investigation|2007Cited by 161
Effect of Antiangiogenic Therapy on Slowly Growing, Poorly Vascularized Tumors in MiceW.-D. Beecken, Yuen Shing, Antonia M. Joussen et al.|JNCI Journal of the National Cancer Institute|2001Cited by 88